MHRA Response to contaminated paediatric medicines
On the 7th of October The Medicines and Healthcare products Regulatory Agency (MHRA) released a response to contaminated paediatric medicines identified by the WHO region of Africa.
The Canada – United Kingdom Trade Continuity Agreement (CUK TCA) Protocol
The Canada – United Kingdom Trade Continuity Agreement (CUK TCA) was entered into force on the 1st of April 2021.
Defective Medicinal Products and Recall Management Guidance
The main concerns with regard to possible defects of medicinal products and the substances used in their manufacture or packaging.
Import Licensed Human Medicine(s) to the United Kingdom (UK) – Guidance
Import Licensed Human Medicine – Prior to importation of a licensed medicine applications for the relevant Licence(s) must be completed and submitted which may include one or more of the following:
Import Unlicensed Human Medicine(s) to the United Kingdom (UK) – guidance
An Introduced Product is an unlicensed medicine which can be imported from a country other than an approved country for import to be exported to a country other than an approved country for import, or if imported from a non-EEA country into Northern Ireland for export back to a country outside the EEA.
